We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 114

New Patent Trial and Appeal Board becomes strategic venue of choice

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 31 2013

According to a news source, companies hoping to prevail in patentinfringement lawsuits have turned with increasing frequency to the Patent Trial and

Federal Circuit upholds inequitable conduct ruling; patent unenforceable

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 17 2013

The Federal Circuit Court of Appeals has determined that a district court did not err in finding that the inequitable conduct of the inventor of

GAO releases report on patent infringement litigation and its consequences

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 12 2013

The America Invents Act (AIA) mandated that the U.S. Government Accountability Office (GAO) conduct a study on the consequences of patent litigation

Federal Circuit applies pre-AIA law to rule it lacked jurisdiction to hear appeal

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 12 2013

The Federal Circuit Court of Appeals has determined that the law in effect before the America Invents Act (AIA) was enacted applied to a dispute

Court orders trial in “patent troll” litigation despite evidence of misconduct

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 29 2013

A federal court in California has denied a motion to dismiss litigation involving a patent assertion entity claiming that the defendant violates its

Ambry Genetics countersues Myriad Genetics in genetic patent infringement suit

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 15 2013

Responding to the patent infringement claims asserted against it by Myriad Genetics, Ambry Genetics Corp. denies that the 15 patents at issue were

CRS report focuses on pharmaceutical patent settlements

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 1 2013

The Congressional Research Service (CRS) recently issued a report titled "Pharmaceutical Patent Settlements: Issues in Innovation and

Myriad Genetics sues diagnostics company over BRCA1 and BRCA2 testing

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 11 2013

Just weeks after the U.S. Supreme Court determined that naturally occurring human genes are not patent eligible and thus found certain Myriad

Federal Circuit panel divides over indirect infringement law

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 11 2013

A split Federal Circuit Court of Appeals panel has determined that an accused inducer's good-faith belief in the invalidity of a patent may negate

Researchers conclude costs of litigation growing in relation to benefits of patent protections

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 20 2013

Economics, law and technology scholars affiliated with U.S. and German institutions have issued a paper that examines data on the costs of patent